| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Institute for Oral Science (X.L., Y.K., N.T.), Department of Biochemistry (N.U., N.S.), Matsumoto Dental University, Nagano 399-0781, Japan; Department of Biochemistry (M.T.), School of Dentistry, Showa University, Tokyo 142-8555, Japan; and Department of Periodontology (N.S.), School of Dentistry, Aichi Gakuin University, Aichi 464-8651, Japan
Address all correspondence and requests for reprints to: Naoyuki Takahashi, Ph.D., Institute for Oral Science, Matsumoto Dental University, 1780 Gobara, Hiro-oka, Shiojiri, Nagano 399-0781, Japan. E-mail: takahashinao{at}po.mdu.ac.jp.
We previously reported that p38 MAPK signaling is required for osteoclast differentiation but not osteoclast function. Here we further investigated the role of p38 MAPK in the function and differentiation of mouse bone marrow macrophages (BMM
), common precursors of osteoclasts and dendritic cells. Lipopolysaccharide (LPS) activated the p38 MAPK signaling pathway in BMM
by sequential phosphorylation of MAPK kinase 3/6, p38 MAPK, and activating transcription factor-2. Treatment of BMM
with SB203580, a p38 MAPK inhibitor, suppressed LPS-induced phosphorylation of activating transcription factor-2. LPS stimulated production of IL-1ß, TNF
, and IL-6 in BMM
, and SB203580 failed to inhibit the LPS-induced cytokine production. BMM
incorporated latex beads via phagocytosis, and SB203580 had no effect on this phagocytosis. BMM
differentiated into dendritic cells when treated with granulocyte macrophage colony-stimulating factor together with CD40 ligand, TNF
, or LPS, and SB203580 failed to inhibit this differentiation. Thus, p38 MAPK-mediated signals are not involved in either BMM
function or BMM
differentiation into dendritic cells. The differentiation of BMM
into osteoclasts in response to receptor activator of nuclear factor-
B ligand or TNF
was strongly inhibited by SB203580. These findings emphasize the crucial roles of p38 MAPK-mediated signaling in osteoclast differentiation.
This article has been cited by other articles:
![]() |
X. Wang, C. H. Goh, and B. Li p38 Mitogen-Activated Protein Kinase Regulates Osteoblast Differentiation through Osterix Endocrinology, April 1, 2007; 148(4): 1629 - 1637. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mochizuki, M. Takami, T. Kawawa, R. Suzumoto, T. Sasaki, A. Shiba, H. Tsukasaki, B. Zhao, R. Yasuhara, T. Suzawa, et al. Identification and Characterization of the Precursors Committed to Osteoclasts Induced by TNF-Related Activation-Induced Cytokine/Receptor Activator of NF-{kappa}B Ligand J. Immunol., October 1, 2006; 177(7): 4360 - 4368. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Medicherla, J. Y. Ma, R. Mangadu, Y. Jiang, J. J. Zhao, R. Almirez, I. Kerr, E. G. Stebbins, G. O'Young, A. M. Kapoun, et al. A Selective p38{alpha} Mitogen-Activated Protein Kinase Inhibitor Reverses Cartilage and Bone Destruction in Mice with Collagen-Induced Arthritis J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 132 - 141. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Chelvarajan, Y. Liu, D. Popa, M. L. Getchell, T. V. Getchell, A. J. Stromberg, and S. Bondada Molecular basis of age-associated cytokine dysregulation in LPS-stimulated macrophages J. Leukoc. Biol., June 1, 2006; 79(6): 1314 - 1327. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kobayashi, I. Take, T. Yamashita, T. Mizoguchi, T. Ninomiya, T. Hattori, S. Kurihara, H. Ozawa, N. Udagawa, and N. Takahashi Prostaglandin E2 Receptors EP2 and EP4 Are Down-regulated during Differentiation of Mouse Osteoclasts from Their Precursors J. Biol. Chem., June 24, 2005; 280(25): 24035 - 24042. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Shiratsuchi and M. D. Basson Activation of p38 MAPK{alpha} by extracellular pressure mediates the stimulation of macrophage phagocytosis by pressure Am J Physiol Cell Physiol, May 1, 2005; 288(5): C1083 - C1093. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-c. Bai, D. Lu, A.-l. Liu, Z.-m. Zhang, X.-m. Li, Z.-p. Zou, W.-s. Zeng, B.-l. Cheng, and S.-q. Luo Reactive Oxygen Species Stimulates Receptor Activator of NF-{kappa}B Ligand Expression in Osteoblast J. Biol. Chem., April 29, 2005; 280(17): 17497 - 17506. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hayer, G. Steiner, B. Gortz, E. Reiter, M. Tohidast-Akrad, M. Amling, O. Hoffmann, K. Redlich, J. Zwerina, K. Skriner, et al. CD44 is a determinant of inflammatory bone loss J. Exp. Med., March 21, 2005; 201(6): 903 - 914. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |